Balaji Amines Q3 FY24: Revenue ₹392 Cr, PAT ₹56 Cr
Q3 FY24 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹383Cr
- +0.5% QoQ
- Net profit
- ₹56Cr
- +55.6% QoQ
- Margin
- 19%
- +5 pp QoQ
Guidance rank: #26 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Balaji Amines Ltd's Q3 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q3FY24 consolidated revenue from operations: ₹392 crore, down 33% YoY from ₹588 crore in Q3FY23 (Page 5, 7). Q3FY24 Consolidated EBITDA: ₹83 crore (up from ₹61 crore in Q2FY24) - Q3FY24 Consolidated EBITDA Margin: 21% (up from 16% in Q2FY24; down YoY from 22% in Q3FY23) - Q3FY24 Consolidated PAT: ₹56 cro
From Balaji Amines Ltd's Q3 FY24 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q3FY24 consolidated revenue from operations: ₹392 crore, down 33% YoY from ₹588 crore in Q3FY23 (Page 5, 7).
- Q3FY24 segmented volumes: Amines 7,703 MT, Amines Derivatives 9,280 MT, Specialty Chemicals 9,920 MT (Page 7).
- Q3FY24 standalone revenue: ₹314 crore, down 24% YoY from ₹416 crore in Q3FY23 (Page 5).
- 9MFY24 consolidated revenue: ₹1,248 crore, down 34% YoY from ₹1,894 crore in 9MFY23 (Page 6).
2 more points from Balaji Amines Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Balaji Amines Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Unit 4 Greenfield Project (90-acre in MIDC Chincholi, Solapur):
- Phase 1 completed: Ethylamines plant (operational May 2021), DMC/PC and PG plants (operational Sep 2022).
- Phase 2 & 3 Capex: Rs. 300-350 crore over FY24 and FY25, mostly internal accruals.
- Phase 2 Expansion:
- N-Butylamine plant (15,000 TPA), targeted commissioning Q4 FY24.
- Methylamine plant (40,000 TPA capacity), commissioning Q2 FY25; company is market leader with 48,000 TPA installed capacity.
- Phase 3 Expansion:
- Dimethyl Ether (DME) plant (100,000 TPA), commissioning H1 FY25.
- Proposed additions: N-Methylmorpholine, Pharmapure Povidone, NBPT.
- Other details:
2 more points from Balaji Amines Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Balaji Amines Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Balaji Amines Ltd — Quarterly revenue & net profit
Balaji Amines Ltd Q3 FY24 results — key figures
| ₹ Cr | Q3 FY24 | Q2 FY24 | QoQ |
|---|---|---|---|
| Revenue | 383 | 381 | +0.5% |
| Operating profit (EBITDA) | 74 | 54 | +37% |
| Operating margin | 19% | 14% | +5 pp |
| Profit before tax | 70 | 48 | +45.8% |
| Net profit (PAT) | 56 | 36 | +55.6% |
| EPS (₹) | 15.24 | 10.71 | +42.3% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹468 Cr, net profit ₹67 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Balaji Amines's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Himadri Special (Q3 FY24)
1,052.51 Cr, up 1.46% YoY from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
- Gujarat Alkalies (Q3 FY24)
3,702.77 crores, down from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
- Vidhi Specialty (Q3 FY24)
Year-on-Year (Y-o-Y) change: -27.1% (Q3 FY24 vs Q3 FY23) . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY24 earnings call — and how it…
- Chemcon Speciality Chemicals (Q3 FY24)
53.0 Cr, down 30.7% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Balaji Amines Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Balaji Amines Ltd Q3 FY24 results?
Q3FY24 consolidated revenue from operations: ₹392 crore, down 33% YoY from ₹588 crore in Q3FY23 (Page 5, 7). Q3FY24 Consolidated EBITDA: ₹83 crore (up from ₹61 crore in Q2FY24) - Q3FY24 Consolidated EBITDA Margin: 21% (up from 16% in Q2FY24; down YoY from 22% in Q3FY23) - Q3FY24 Consolidated PAT: ₹56 cro
What is Balaji Amines Ltd share price analysis?
Balaji Amines Ltd currently shows a neutral. The stock trades at a P/E of 34.5 with a market cap of ₹7,036 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Balaji Amines Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
